DZ1759A1 - Produits pharmaceutiques à base d'acide nucleique. - Google Patents

Produits pharmaceutiques à base d'acide nucleique.

Info

Publication number
DZ1759A1
DZ1759A1 DZ940021A DZ940021A DZ1759A1 DZ 1759 A1 DZ1759 A1 DZ 1759A1 DZ 940021 A DZ940021 A DZ 940021A DZ 940021 A DZ940021 A DZ 940021A DZ 1759 A1 DZ1759 A1 DZ 1759A1
Authority
DZ
Algeria
Prior art keywords
nucleic acid
pharmaceutical products
products based
pharmaceutical
nucleic
Prior art date
Application number
DZ940021A
Other languages
English (en)
Inventor
Suezanne E Parker
Donna L Montgomery
Margaret A Liu
Jeffrey B Ulmer
Varavani J Dwarki
John J Donnelly
John W Shiver
Original Assignee
Merck & Co Inc
Vical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc, Vical Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of DZ1759A1 publication Critical patent/DZ1759A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
DZ940021A 1993-03-18 1994-03-16 Produits pharmaceutiques à base d'acide nucleique. DZ1759A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3238393A 1993-03-18 1993-03-18
US8998593A 1993-07-08 1993-07-08

Publications (1)

Publication Number Publication Date
DZ1759A1 true DZ1759A1 (fr) 2002-02-17

Family

ID=26708344

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ940021A DZ1759A1 (fr) 1993-03-18 1994-03-16 Produits pharmaceutiques à base d'acide nucleique.

Country Status (22)

Country Link
EP (1) EP0620277A1 (fr)
JP (2) JP2812352B2 (fr)
CN (1) CN1119458A (fr)
AU (1) AU676258B2 (fr)
BG (1) BG63126B1 (fr)
BR (1) BR9406007A (fr)
CA (1) CA2119175A1 (fr)
CZ (1) CZ290315B6 (fr)
DZ (1) DZ1759A1 (fr)
FI (1) FI954329A (fr)
HR (1) HRP940175A2 (fr)
HU (1) HUT73397A (fr)
IL (1) IL108915A0 (fr)
NO (1) NO953649L (fr)
NZ (1) NZ263680A (fr)
PL (1) PL178626B1 (fr)
RO (1) RO117710B1 (fr)
SI (1) SI9420014A (fr)
SK (1) SK114295A3 (fr)
UA (1) UA42715C2 (fr)
WO (1) WO1994021797A1 (fr)
YU (1) YU12894A (fr)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849719A (en) * 1993-08-26 1998-12-15 The Regents Of The University Of California Method for treating allergic lung disease
US6911216B1 (en) 1994-10-12 2005-06-28 Genzyme Corporation Targeted delivery via biodegradable polymers
US5736524A (en) * 1994-11-14 1998-04-07 Merck & Co.,. Inc. Polynucleotide tuberculosis vaccine
DE19512142A1 (de) * 1995-03-31 1996-10-02 Immuno Ag Infektiöser cDNA-Klon des Tick-Borne Enzephalitis (TBE)-Virus, davon abgeleiteter rekombinanter Impfstoff und Herstellung desselben sowie ein pharmazeutisches Produkt, das eine replizierbare Nukleinsäure enthält
US6019980A (en) 1995-06-07 2000-02-01 Connaught Laboratories Limited Nucleic acid respiratory syncytial virus vaccines
US6083925A (en) 1995-06-07 2000-07-04 Connaught Laboratories Limited Nucleic acid respiratory syncytial virus vaccines
US6017897A (en) * 1995-06-07 2000-01-25 Pasteur Merieux Connaught Canada Nucleic acid respiratory syncytial virus vaccines
US6537776B1 (en) 1999-06-14 2003-03-25 Diversa Corporation Synthetic ligation reassembly in directed evolution
FR2751225B1 (fr) * 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique aviaire
US6204250B1 (en) 1996-11-22 2001-03-20 The Mount Sinai Medical Center Of The City Of New York Immunization of infants
EP1017283B1 (fr) * 1997-02-14 2004-12-15 Merck & Co., Inc. Formules de vaccins a base de polynucleotides
US6517843B1 (en) 1999-08-31 2003-02-11 Merial Reduction of porcine circovirus-2 viral load with inactivated PCV-2
UA78180C2 (uk) 1997-10-03 2007-03-15 Меріаль Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
FR2772047B1 (fr) 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
US6693087B1 (en) 1998-08-20 2004-02-17 Aventis Pasteur Limited Nucleic acid molecules encoding POMP91A protein of Chlamydia
US6686339B1 (en) 1998-08-20 2004-02-03 Aventis Pasteur Limited Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia
EP1105490A1 (fr) 1998-08-20 2001-06-13 Aventis Pasteur Limited Molecules d'acide nucleique codant la proteine membrane d'inclusion c de chlamydia
US6881723B1 (en) 1998-11-05 2005-04-19 Powderject Vaccines, Inc. Nucleic acid constructs
US7618797B2 (en) 1998-12-22 2009-11-17 Pfizer Inc Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
US7691389B2 (en) 1998-12-22 2010-04-06 Pfizer Inc Infectious cDNA clone of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
WO2000047227A2 (fr) 1999-02-09 2000-08-17 Powderject Vaccines, Inc. IMMUNISATION CONTRE $i(MYCOBACTERIUM TUBERCULOSIS)
US6943152B1 (en) 1999-06-10 2005-09-13 Merial DNA vaccine-PCV
JP2001151698A (ja) * 1999-09-10 2001-06-05 Nichiko Pharmaceutical Co Ltd インフルエンザワクチン
AU1013701A (en) 1999-10-22 2001-05-08 Aventis Pasteur Limited Modified gp100 and uses thereof
US7196066B1 (en) 1999-11-03 2007-03-27 Powderject Vaccines, Inc. DNA-vaccines based on constructs derived from the genomes of human and animal pathogens
US6852705B2 (en) 2000-01-21 2005-02-08 Merial DNA vaccines for farm animals, in particular bovines and porcines
US7078388B2 (en) 2000-01-21 2006-07-18 Merial DNA vaccines for farm animals, in particular bovines and porcines
EP1792995A3 (fr) 2000-05-08 2007-06-13 Sanofi Pasteur Limited Antigènes de chlamydia et fragments d'adn correspondants, et utilisations de ceux-ci
AU5810201A (en) 2000-05-10 2001-11-20 Aventis Pasteur Immunogenic polypeptides encoded by mage minigenes and uses thereof
WO2005116270A2 (fr) 2004-05-18 2005-12-08 Vical Incorporated Composition de vaccin contre le virus de la grippe et ses methodes d'utilisation
US8202967B2 (en) 2006-10-27 2012-06-19 Boehringer Ingelheim Vetmedica, Inc. H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
AU2008260023A1 (en) * 2007-05-31 2008-12-11 Becton, Dickinson And Company Sequences and methods for detecting influenza A and influenza B virus
US8354230B2 (en) * 2007-12-21 2013-01-15 Quest Diagnostics Investments Inc. Multiplex detection assay for influenza and RSV viruses
EP2318044B1 (fr) 2008-08-01 2015-12-02 Gamma Vaccines Pty Limited Vaccins contre la grippe
CA2760553A1 (fr) 2009-04-30 2010-11-04 Jr. James E. Crowe Anticorps monoclonaux contre le virus de la grippe h1n1 et ses utilisations
SG168423A1 (en) * 2009-07-13 2011-02-28 Agency Science Tech & Res Influenza detection method and kit therefor
AR078253A1 (es) 2009-09-02 2011-10-26 Boehringer Ingelheim Vetmed Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad
AR083533A1 (es) 2010-10-22 2013-03-06 Boehringer Ingelheim Vetmed Proteinas de hemaglutinina 5 (h5) para el tratamiento y prevencion de las infecciones de gripe
AR088028A1 (es) 2011-08-15 2014-05-07 Boehringer Ingelheim Vetmed Proteinas h5, de h5n1 para un uso medicinal
WO2013033092A2 (fr) 2011-09-03 2013-03-07 Boehringer Ingelheim Vetmedica Gmbh Antigènes de poil de streptococcus suis
WO2013138118A1 (fr) 2012-03-14 2013-09-19 The Regents Of The University Of California Traitement de troubles inflammatoires chez des mammifères non humains
EP2958586B1 (fr) 2013-02-21 2018-09-05 Boehringer Ingelheim Vetmedica GmbH Protéines h5 du virus de la grippe h5n1 pour utilisation en tant que médicament
KR102379951B1 (ko) * 2013-03-18 2022-03-31 오시벡스 에스에이에스 인플루엔자 핵단백질 백신
JP6821429B2 (ja) 2013-09-25 2021-01-27 ゾエティス・サービシーズ・エルエルシー Ｐｃｖ２ｂ分岐ワクチン組成物及び使用方法
JP6395855B2 (ja) 2014-04-03 2018-09-26 ベーリンガー インゲルハイム フェトメディカ インコーポレイテッド ブタ流行性下痢ウイルスワクチン
UA124140C2 (uk) 2015-08-31 2021-07-28 Бьорінгер Інгельхайм Ветмедіка Гмбх Пестивірусна вакцина проти вродженого тремору поросят
JP2018526454A (ja) 2015-09-16 2018-09-13 ベーリンガー インゲルハイム フェトメディカ インコーポレイテッド ブタコレラ菌−ネズミチフス菌ワクチン
TW201823467A (zh) 2016-09-20 2018-07-01 德商百靈佳殷格翰維美迪加股份有限公司 犬腺病毒載體
WO2018054822A1 (fr) 2016-09-20 2018-03-29 Boehringer Ingelheim Vetmedica Gmbh Nouveau vaccin contre la grippe porcine
TWI817933B (zh) 2016-09-20 2023-10-11 德商百靈佳殷格翰維美迪加股份有限公司 新穎ehv插入位點orf70
NZ751966A (en) 2016-09-20 2023-03-31 Boehringer Ingelheim Vetmedica Gmbh New promoters
MX2019005136A (es) 2016-11-03 2019-06-20 Boehringer Ingelheim Vetmedica Gmbh Vacuna contra el parvovirus porcino y el virus del sindrome respiratorio reproductivo porcino y metodos de produccion de esta.
BR112019009133A2 (pt) 2016-11-03 2019-07-16 Boehringer Ingelheim Vetmedica Gmbh vacina contra o parvovírus suíno
EP3573655A2 (fr) 2017-01-30 2019-12-04 Boehringer Ingelheim Animal Health USA Inc. Vaccins contre le coronavirus porcin
CN110869047A (zh) 2017-07-12 2020-03-06 勃林格殷格翰动物保健美国有限公司 塞内卡病毒a免疫原性组合物及其方法
EA202090628A1 (ru) 2017-09-23 2020-11-16 Бёрингер Ингельхайм Ветмедика Гмбх Система экспрессии paramyxoviridae
WO2019092027A1 (fr) 2017-11-09 2019-05-16 Boehringer Ingelheim Vetmedica Gmbh Compositions immunogènes à base de sapelovirus et leurs utilisations
AU2019223768A1 (en) 2018-02-23 2020-08-27 Boehringer Ingelheim Animal Health USA Inc. Recombinant viral vector systems expressing exogenous feline paramyxovirus genes and vaccines made therefrom
WO2019179966A1 (fr) 2018-03-19 2019-09-26 Boehringer Ingelheim Vetmedica Gmbh Site d'insertion d'ehv ul43
JP7273840B2 (ja) 2018-03-19 2023-05-15 ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー 不活性化ｕｌ１８および／またはｕｌ８を有する新しいｅｈｖ
JP7162072B2 (ja) 2018-03-26 2022-10-27 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド 免疫原性組成物を製造する方法
TW202027785A (zh) 2018-09-20 2020-08-01 德商百靈佳殷格翰維美迪加股份有限公司 經修飾之pedv棘蛋白
WO2020058341A1 (fr) 2018-09-20 2020-03-26 Boehringer Ingelheim Vetmedica Gmbh Vaccin à vecteur par voie intranasale contre la diarrhée épidémique porcine
IT201900007060A1 (it) 2019-05-21 2020-11-21 St Superiore Di Sanita Cellule tumorali ingegnerizzate e loro usi
IT201900012540A1 (it) 2019-07-22 2021-01-22 Humanitas Mirasole Spa Inibitori di CHI3L1 e loro usi
EP4100420A1 (fr) 2020-02-06 2022-12-14 Boehringer Ingelheim Vetmedica GmbH Polypeptides utiles pour la détection d'anticorps anti-rhabdovirus
MX2023004006A (es) 2020-10-05 2023-04-26 Boehringer Ingelheim Vetmedica Gmbh Proteina fusion util para la vacunacion contra el rotavirus.
US20220160864A1 (en) 2020-10-05 2022-05-26 Boehringer Ingelheim Animal Health USA Inc. Fusion protein comprising circoviridae capsid protein, and chimeric virus-like particles composed thereof
US20240050555A1 (en) 2022-04-05 2024-02-15 Boehringer Ingelheim Vetmedica Gmbh Immunogenic composition useful for vaccination against rotavirus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL86354A0 (en) * 1987-05-22 1988-11-15 Orion Yhtymae Oy Episomal vector for the expression of selected dna fragments coding for optional polypeptides in mammalian cells and methods for the production thereof
EP1026253B2 (fr) * 1989-03-21 2012-12-19 Vical Incorporated Expression de séquences polynucléotidiques exogènes chez un vertébré
US5643578A (en) * 1992-03-23 1997-07-01 University Of Massachusetts Medical Center Immunization by inoculation of DNA transcription unit

Also Published As

Publication number Publication date
BR9406007A (pt) 1996-01-02
YU12894A (sh) 1997-12-05
IL108915A0 (en) 1994-06-24
PL310677A1 (en) 1995-12-27
NZ263680A (en) 1997-05-26
WO1994021797A1 (fr) 1994-09-29
CZ237395A3 (en) 1996-02-14
HUT73397A (en) 1996-07-29
EP0620277A1 (fr) 1994-10-19
HRP940175A2 (en) 1997-04-30
JPH0795888A (ja) 1995-04-11
JP2812352B2 (ja) 1998-10-22
AU676258B2 (en) 1997-03-06
NO953649D0 (no) 1995-09-15
BG63126B1 (bg) 2001-04-30
UA42715C2 (uk) 2001-11-15
JP3608642B2 (ja) 2005-01-12
HU9502702D0 (en) 1995-11-28
SI9420014A (en) 1996-08-31
CA2119175A1 (fr) 1994-09-19
NO953649L (no) 1995-11-17
CZ290315B6 (cs) 2002-07-17
BG100006A (bg) 1996-12-31
CN1119458A (zh) 1996-03-27
SK114295A3 (en) 1996-02-07
AU5788994A (en) 1994-09-22
PL178626B1 (pl) 2000-05-31
FI954329A0 (fi) 1995-09-14
RO117710B1 (ro) 2002-06-28
JPH10113194A (ja) 1998-05-06
FI954329A (fi) 1995-09-14

Similar Documents

Publication Publication Date Title
DZ1759A1 (fr) Produits pharmaceutiques à base d'acide nucleique.
FR2705566B1 (fr) Nouvelles compositions pharmaceutiques.
FI903382A0 (fi) Topiskt anbringbara farmaceutiska preparat.
FI873630A (fi) Stabilt farmaceutiskt preparat.
ITRM920237A1 (it) Perfezionato impiego di medicinali broncodilatatori b2.
MA22443A1 (fr) Procede de preparation d'une composition pharmaceutique .
AU1706788A (en) 2-(3,4-dihydroxyphenyl)ethylamines, and their use pharmaceutical compositions
TR199501082A2 (tr) Farmasötik formülasyonlar.
DE3865908D1 (de) Ibuprofen enthaltendes pharmazeutisches mittel.
DK86492D0 (da) Laegemiddel
FI955605A (fi) Aryloivia lääkkeitä
FR2705569B1 (fr) Composition pharmaceutique à base d'une imidazolylcarbazolone destinée à l'administration rectale.
MA23133A1 (fr) Derives d'acide d'acyloxyhexanoique .
FR2703336B1 (fr) Perfectionnements apportes aux emballages supports d'ampoules pharmaceutiques ou autres produits.
FR2720936B1 (fr) Poudres à base de métoclopramide et de paracétamol ou de dérivés d'acide acétylsalicylique.
FI883747A (fi) Topiskt anvaendbara farmaceutiska preparat.
DZ2159A1 (fr) Produits pharmaceutiques.
DE69000953D1 (de) Produkt-stabilisator.
ATA121092A (de) Monomerzubereitungen fuer die bauindustrie
FR2710042B1 (fr) Dispositif d'empilage de produits.
FR2717692B1 (fr) Nouvelle composition médicamenteuse à base d'argile.
FR2676364B1 (fr) Composition pharmaceutique a base de derives d'aminobutanone.
OA08504A (fr) Produits insecticides à base d'endosulfan
FR2655460B1 (fr) Presentoir d'affiches.
FR2682795B3 (fr) Support d'affichage.